Andrew B. Lassman, MD
Chief, Neuro-Oncology Division
Department of Neurology
Columbia University Irving Medical Center
New York, New York
Andrew B. Lassman, MD, has disclosed that he has received research support paid to his institution from AbbVie, Aeterna Zenaris, Bayer, BeiGene, Bristol-Myers Squibb, Chimerix, Corden, DelMar, Genentech/Roche, Kadmon, Karyopharm, Kazia, Millennium, NextSource, Novartis, Novocure, Orbus, Pfizer, QED, Semus, Servier, and VBI Vaccines, consulting fees from Bayer, Bioclinica as a blinded reader for a BMS-sponsored trial, Karyopharm, Novocure, Orbus, Sapience, and Vivacitas, and travel/in-kind support from AbbVie, Karyopharm, Novartis, Pfizer, QED, and VBI Vaccines.